RASGEF1B: A Potential Drug Target Or Biomarker (G153020)

Target Name: RASGEF1B

NCBI ID: G153020

RASGEF1B

RASGEF1B: A Potential Drug Target Or Biomarker

RASGEF1B (RAS gene 1B) is a gene that encodes a protein known as RASGEF1B, which plays a critical role in cell signaling pathways. RASGEF1B is a 21-kDa protein that consists of 158 amino acid residues. It is localized to the cytoplasm and is involved in various cellular processes, including cell adhesion, migration, and invasion.

The RASGEF1B gene has been identified as a potential drug target or biomarker due to its involvement in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Several studies have suggested that RASGEF1B may be a useful target for drug development due to its unique structure and its involvement in cellular signaling pathways.

One of the key advantages of RASGEF1B as a drug target is its expression profile. RASGEF1B is highly expressed in various tissues and organs, including brain, heart, liver, and pancreas. It is also expressed in various cell types, including epithelial cells, endothelial cells, and immune cells. This makes RASGEF1B an attractive target for drug development due to its potential availability in a variety of biological samples.

Another advantage of RASGEF1B is its involvement in various cellular signaling pathways. RASGEF1B is a key regulator of the RAS/MAPK signaling pathway, which is involved in various cellular processes, including cell adhesion, migration, and invasion. This makes RASGEF1B a potential target for drugs that target this pathway.

In addition to its involvement in the RAS/MAPK signaling pathway, RASGEF1B is also involved in the Focal Adhesion Molecule (FAM) pathway. This pathway is involved in cell adhesion and is a potential target for drugs that target this pathway.

The high expression level of RASGEF1B in various tissues and cell types also makes it an attractive target for drugs that target this gene. This gene has been shown to be involved in various cellular processes, including cell adhesion, migration, and invasion. This makes RASGEF1B a potential target for drugs that target this gene.

In conclusion, RASGEF1B is a gene that has been identified as a potential drug target or biomarker due to its unique structure and its involvement in various cellular signaling pathways. Further research is needed to determine the full potential of RASGEF1B as a drug target or biomarker.

Protein Name: RasGEF Domain Family Member 1B

Functions: Guanine nucleotide exchange factor (GEF) with specificity for RAP2A, it doesn't seems to activate other Ras family proteins (in vitro)

The "RASGEF1B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RASGEF1B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets